Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion
FREVO
Dynamic Assessment of Fluid Responsiveness and Venous Congestion: Evolution of the VExUS Score During Volume Expansion
1 other identifier
observational
64
2 countries
3
Brief Summary
Fluid responsiveness is a critical determinant guiding fluid therapy in critically ill patients. However, excessive fluid administration can result in fluid overload, leading to venous congestion and worse clinical outcomes. Venous congestion, a marker of impaired fluid clearance, is increasingly recognized as a significant contributor to poor prognosis. Previous studies have demonstrated the coexistence of fluid responsiveness and venous congestion in critically ill patients. Notably, these studies were limited by the absence of fluid challenge-the gold standard for assessing fluid responsiveness-leaving the dynamic relationship between fluid responsiveness and venous congestion incompletely understood. This study aims to investigate the interplay and temporal evolution of fluid responsiveness and venous congestion following a standardized fluid challenge in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2025
CompletedFirst Submitted
Initial submission to the registry
January 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedJanuary 13, 2025
December 1, 2024
6 months
January 8, 2025
January 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The difference in venous congestion (VExUS) changes between fluid responders and non-responders following a fluid challenge.
before and after 15-minute fluid challenge.
Secondary Outcomes (1)
The differential evolution of venous congestion (VExUS) changes between fluid responders and non-responders 1 hour after a fluid challenge.
1 hour after fluid challenge
Study Arms (2)
Fluid Responder
Patients with an aumentation of cardiac index\>= 15% after a fluid challenge
Fluid Non-responder
Patients without an aumentation of cardiac index\>= 15% after a fluid challenge
Eligibility Criteria
Critically ill patients with evidence of inadequate tissue perfusion, who are already monitored using a pulse wave contour analysis-derived estimation of cardiac output (either calibrated or uncalibrated),and for whom clinicians have decided to administer volume expansion through intravenous crystalloid infusion.
You may qualify if:
- Age ≥ 18 years
- Hospitalized in the intensive care unit (ICU)
- Hemodynamic monitoring in place, with a pulse wave contour analysis- derived estimation of cardiac output (either calibrated or uncalibrated)
- Decision made by clinicians to perform volume expansion through intravenous infusion of crystalloid fluid
You may not qualify if:
- Pregnancy
- Refusal to participate by relatives of the patient or the patient himself
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bicetre Hospitallead
- First Affiliated Hospital, Sun Yat-Sen Universitycollaborator
- Longgang District People's Hospital of Shenzhencollaborator
Study Sites (3)
First affiliated Hospital , Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Longgang Central Hospital of Shenzhen
Shenzhen, Guangdong, 518116, China
Bicetre Hospital
Paris, Val-de-Marne, 94270, France
Related Publications (5)
Munoz F, Born P, Bruna M, Ulloa R, Gonzalez C, Philp V, Mondaca R, Blanco JP, Valenzuela ED, Retamal J, Miralles F, Wendel-Garcia PD, Ospina-Tascon GA, Castro R, Rola P, Bakker J, Hernandez G, Kattan E. Coexistence of a fluid responsive state and venous congestion signals in critically ill patients: a multicenter observational proof-of-concept study. Crit Care. 2024 Feb 19;28(1):52. doi: 10.1186/s13054-024-04834-1.
PMID: 38374167BACKGROUNDMonnet X, Shi R, Teboul JL. Prediction of fluid responsiveness. What's new? Ann Intensive Care. 2022 May 28;12(1):46. doi: 10.1186/s13613-022-01022-8.
PMID: 35633423BACKGROUNDMessina A, Calabro L, Pugliese L, Lulja A, Sopuch A, Rosalba D, Morenghi E, Hernandez G, Monnet X, Cecconi M. Fluid challenge in critically ill patients receiving haemodynamic monitoring: a systematic review and comparison of two decades. Crit Care. 2022 Jun 21;26(1):186. doi: 10.1186/s13054-022-04056-3.
PMID: 35729632BACKGROUNDMonnet X, Malbrain MLNG, Pinsky MR. The prediction of fluid responsiveness. Intensive Care Med. 2023 Jan;49(1):83-86. doi: 10.1007/s00134-022-06900-0. Epub 2022 Nov 3. No abstract available.
PMID: 36323911BACKGROUNDJoseph A, Petit M, Vignon P, Vieillard-Baron A. Fluid responsiveness and venous congestion: unraveling the nuances of fluid status. Crit Care. 2024 Apr 26;28(1):140. doi: 10.1186/s13054-024-04930-2. No abstract available.
PMID: 38671461BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Xavier Monnet, MD, PHD
Study Record Dates
First Submitted
January 8, 2025
First Posted
January 13, 2025
Study Start
January 5, 2025
Primary Completion
June 30, 2025
Study Completion
July 30, 2025
Last Updated
January 13, 2025
Record last verified: 2024-12